NumerixS Investment Technologies’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-300
Closed -$8K 360
2020
Q2
$8K Sell
300
-3,421
-92% -$77.2K ﹤0.01% 1007
2020
Q1
$67K Sell
3,721
-16,479
-82% -$313K 0.03% 544
2019
Q4
$358K Buy
+20,200
New +$350K 0.07% 321
2019
Q3
Sell
-2,390
Closed -$41K 1098
2019
Q2
$41K Buy
2,390
+990
+71% +$16K 0.01% 806
2019
Q1
$22K Sell
1,400
-1,300
-48% -$21.1K ﹤0.01% 1060
2018
Q4
$39K Sell
2,700
-15,100
-85% -$241K 0.01% 818
2018
Q3
$320K Buy
17,800
+4,300
+32% +$75.3K 0.06% 422
2018
Q2
$230K Sell
13,500
-14,500
-52% -$274K 0.05% 470
2018
Q1
$530K Buy
28,000
+18,313
+189% +$355K 0.13% 178
2017
Q4
$196K Sell
9,687
-13,500
-58% -$248K 0.04% 465
2017
Q3
$403K Sell
23,187
-42,700
-65% -$578K 0.09% 287
2017
Q2
$845K Buy
65,887
+47,304
+255% +$632K 0.12% 201
2017
Q1
$241K Sell
18,583
-21,017
-53% -$266K 0.03% 661
2016
Q4
$391K Buy
+39,600
New +$434K 0.05% 464
2016
Q3
Sell
-3,700
Closed -$32K 1193
2016
Q2
$32K Buy
+3,700
New +$36.5K ﹤0.01% 1010
2016
Q1
Sell
-11,800
Closed -$204K 887
2015
Q4
$204K Sell
11,800
-10,700
-48% -$171K 0.03% 694
2015
Q3
$302K Buy
+22,500
New +$452K 0.03% 515

Other funds holding HALO

NumerixS Investment Technologies's HALO Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Halozyme (HALO) in Q3 2020, closing a stake of 300 shares — an estimated $8K sold.

NumerixS Investment Technologies first reported a position in HALO in Q3 2015 and held it in 17 quarters. The position peaked at $845K in Q2 2017. 268 funds tracked by Wall St. Rank hold HALO as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Halozyme position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 300 Halozyme shares in Q3 2020, an estimated $8K.
  • NumerixS Investment Technologies first reported a position in Halozyme in Q3 2015 and held it in 17 quarters.
  • NumerixS Investment Technologies's Halozyme position peaked at $845K in Q2 2017.
  • 268 funds tracked by Wall St. Rank held Halozyme as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.